
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

'Knock out the middlemen' is a campaign promise Donald Trump should keep
Congressional leaders in December struck a deal to rein in PBM practices, but the bill fell apart. President Trump has pledged to “knock out the middlemen ” in health care, so the time is ripe for Congress to reconsider the issue.

Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on the industry for the last four years.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.